Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
23.6% YoY to THB 343mn Full-quarter recognition of ‘International Advertising’ Recognised net loss from non-recurring expenses of THB 180mn from impairment of assets, loss on disposal/ write-off of
reduction in customer contact leads to a decrease in selling expenses such as expenses related to customers, etc. Furthermore, the cost of impairment loss on financial assets in 2021 decreased by 93.4 million
(financial or otherwise), results of operations, operations, assets (including properties and licenses) or liabilities of Kerry in the amount of more than THB 20,000,000. 2. Share Subscription Agreement 2.1
expenses was 1,719 MTHB, increased by 546 MTHB or 47% from 2016. This increment was mainly from the loss on written-off and disposal of plant and equipments and intangible assets of Solvay Biochemicals
. Analysis of financial status as at 30 September 2020 (Unit: Million Baht) Assets 30 Sep. 2020 % 30 Sep. 2019 % Trade and other receivables 459.99 22.49% 315.22 19% Inventories 140.18 6.85% 116.98 7% Lease
customer base while also preparing to accommodate new clients this year. Moreover, there was an additional depreciation calculated by the investment in assets used in production to boost efficiency and
additional depreciation calculated by the investment in assets used in production to boost efficiency and reduce production costs in the long run. - Net profit according to the financial statement decreased by
Company’s process of changing its customer base while also preparing to accommodate new clients. Moreover, there was an additional depreciation calculated by the investment in assets used in production to